ZIVO logo

ZIVO Bioscience (ZIVO) EBITDA

Annual EBITDA

-$7.26 M
+$1.47 M+16.82%

December 31, 2023

Summary

Performance

1-Year Change

+16.82%

3-Year Change

+15.11%

5-Year Change

-11.09%

15-Year Change

-2.72%

ZIVO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.67%
ZIVO annual EBITDA is higher than 69.67% of companies in Healthcare sector

High & Low

All-time High

$1.22 M
ZIVO annual EBITDA is currently -694.65% below its historical high of $1.22 million

3-Year Low

-$8.73 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ZIVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 13, 2025
ZIVO next annual earnings announcement is scheduled for May 13, 2025

OtherZIVOprofitabilitymetrics:

Annual Revenue

$27.70 K
ZIVO annual revenue is $27.70 thousand

Annual Net Income

-$7.78 M
ZIVO annual net profit is -$7.78 million

Annual EBIT

-$7.26 M
ZIVO annual earnings before interest & taxes is -$7.26 million

Annual EPS

-$4.60
ZIVO annual earnings per share is -$4.60

Quarterly EBITDA

-$2.26 M
+$5.97 M+72.54%

September 30, 2024

Summary

Performance

3-Month Change

+72.54%

1-Year Change

-19.16%

3-Year Change

+14.32%

5-Year Change

+14.32%

ZIVO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.68%
ZIVO quarterly EBITDA is higher than 60.68% of companies in Healthcare sector

High & Low

All-time High

$4.11 M
ZIVO quarterly EBITDA is currently -155.01% below its historical high of $4.11 million

3-Year Low

-$8.23 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZIVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 13, 2025
ZIVO next earnings announcement is scheduled for May 13, 2025

OtherZIVOprofitabilitymetrics:

Quarterly Revenue

$31.50 K
ZIVO quarterly revenue is $31.50 thousand

Quarterly Net Income

-$2.27 M
ZIVO quarterly net profit is -$2.27 million

Quarterly EBIT

-$2.26 M
ZIVO quarterly earnings before interest & taxes is -$2.26 million

Quarterly EPS

-$0.67
ZIVO quarterly earnings per share is -$0.67

TTM EBITDA

-$13.66 M
-$687.60 K-5.30%

September 30, 2024

Summary

Performance

3-Month Change

-5.3%

1-Year Change

-88.1%

3-Year Change

-56.46%

5-Year Change

-56.46%

ZIVO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.44%
ZIVO TTM EBITDA is higher than 56.44% of companies in Healthcare sector

High & Low

All-time High

$1.22 M
ZIVO TTM EBITDA is currently -1218.55% below its historical high of $1.22 million

3-Year Low

-$13.66 M
ZIVO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZIVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 13, 2025
ZIVO next earnings announcement is scheduled for May 13, 2025

OtherZIVOprofitabilitymetrics:

TTM Revenue

$79.00 K
ZIVO TTM revenue is $79.00 thousand

TTM Net Income

-$13.69 M
ZIVO TTM net profit is -$13.69 million

TTM EBIT

-$13.66 M
ZIVO TTM earnings before interest & taxes is -$13.66 million

TTM EPS

-$4.88
ZIVO TTM earnings per share is -$4.88

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$7.26 M
ZIVO annual EBITDA is -$7.26 million

Annual Net Income

-$7.78 M
ZIVO annual net profit is -$7.78 million

Annual Interest Expense

$514.20 K
ZIVO annual interest expense is $514.20 thousand

Annual Income Tax

-
ZIVO annual income tax value is unknown

Annual D&A

-
ZIVO annual depreciation & amortization value is unknown

ZIVO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.8%-19.2%-88.1%
3 y3 years+15.1%+14.3%-56.5%
5 y5 years-11.1%+14.3%-56.5%

ZIVO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+16.8%-77.1%+72.5%-108.0%at low
5 y5-yearat high+16.8%-119.4%+72.5%-108.0%at low
alltimeall time-694.6%+24.3%-155.0%+72.5%-1218.5%at low

ZIVO Bioscience EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.26 M(-72.5%)
-$13.66 M(+5.3%)
Jun 2024
-
-$8.23 M(+545.1%)
-$12.97 M(+97.5%)
Mar 2024
-
-$1.28 M(-32.7%)
-$6.57 M(-9.6%)
Dec 2023
-$7.26 M(-16.8%)
-$1.90 M(+20.6%)
-$7.26 M(-9.3%)
Sep 2023
-
-$1.57 M(-13.8%)
-$8.00 M(-5.1%)
Jun 2023
-
-$1.82 M(-7.4%)
-$8.43 M(-2.8%)
Mar 2023
-
-$1.97 M(-25.3%)
-$8.68 M(-0.6%)
Dec 2022
-$8.73 M(+2.5%)
-$2.64 M(+31.9%)
-$8.73 M(-6.7%)
Sep 2022
-
-$2.00 M(-3.3%)
-$9.36 M(+5.0%)
Jun 2022
-
-$2.07 M(+2.0%)
-$8.91 M(+3.7%)
Mar 2022
-
-$2.03 M(-37.9%)
-$8.59 M(-0.7%)
Dec 2021
-$8.52 M(-0.4%)
-$3.26 M(+110.4%)
-$8.65 M(+21.1%)
Sep 2021
-
-$1.55 M(-11.3%)
-$7.14 M(-20.3%)
Jun 2021
-
-$1.75 M(-16.0%)
-$8.95 M(+8.7%)
Mar 2021
-
-$2.08 M(+18.7%)
-$8.23 M(-3.8%)
Dec 2020
-$8.56 M(+2.4%)
-$1.75 M(-47.8%)
-$8.56 M(-19.1%)
Sep 2020
-
-$3.36 M(+226.7%)
-$10.57 M(+20.4%)
Jun 2020
-
-$1.03 M(-57.2%)
-$8.78 M(-10.3%)
Mar 2020
-
-$2.41 M(-36.2%)
-$9.79 M(+17.2%)
Dec 2019
-$8.35 M(+27.7%)
-$3.77 M(+139.7%)
-$8.35 M(+34.5%)
Sep 2019
-
-$1.57 M(-22.7%)
-$6.21 M(+1.1%)
Jun 2019
-
-$2.04 M(+110.5%)
-$6.14 M(+11.1%)
Mar 2019
-
-$967.90 K(-40.6%)
-$5.53 M(-15.4%)
Dec 2018
-$6.54 M(-7.5%)
-$1.63 M(+8.1%)
-$6.54 M(-13.4%)
Sep 2018
-
-$1.51 M(+5.8%)
-$7.55 M(-9.2%)
Jun 2018
-
-$1.43 M(-27.8%)
-$8.31 M(+7.1%)
Mar 2018
-
-$1.97 M(-25.3%)
-$7.76 M(+9.4%)
Dec 2017
-$7.07 M(+42.1%)
-$2.64 M(+16.3%)
-$7.10 M(+33.3%)
Sep 2017
-
-$2.27 M(+159.6%)
-$5.33 M(+35.1%)
Jun 2017
-
-$875.20 K(-33.2%)
-$3.94 M(-23.0%)
Mar 2017
-
-$1.31 M(+50.5%)
-$5.12 M(+2.9%)
Dec 2016
-$4.98 M(-1.3%)
-$870.00 K(-1.9%)
-$4.98 M(+1.4%)
Sep 2016
-
-$886.60 K(-56.8%)
-$4.91 M(-7.4%)
Jun 2016
-
-$2.05 M(+76.1%)
-$5.30 M(+4.3%)
Mar 2016
-
-$1.17 M(+45.9%)
-$5.08 M(+0.7%)
Dec 2015
-$5.04 M(-512.9%)
-$799.30 K(-37.6%)
-$5.04 M(+49.2%)
Sep 2015
-
-$1.28 M(-30.2%)
-$3.38 M(-36.1%)
Jun 2015
-
-$1.83 M(+62.5%)
-$5.29 M(+31.6%)
Mar 2015
-
-$1.13 M(-230.6%)
-$4.02 M(-428.8%)
Dec 2014
$1.22 M(-112.7%)
$864.50 K(-127.1%)
$1.22 M(+36.3%)
Sep 2014
-
-$3.19 M(+463.4%)
$896.00 K(-277.5%)
Jun 2014
-
-$565.50 K(-113.8%)
-$504.80 K(-75.8%)
Mar 2014
-
$4.11 M(+662.1%)
-$2.09 M(-70.3%)
Dec 2013
-$9.60 M(+340.0%)
$539.10 K(-111.8%)
-$7.03 M(-6.8%)
Sep 2013
-
-$4.59 M(+113.4%)
-$7.54 M(+117.9%)
Jun 2013
-
-$2.15 M(+159.2%)
-$3.46 M(+136.6%)
Mar 2013
-
-$829.20 K(-3277.0%)
-$1.46 M(+8.3%)
Dec 2012
-$2.18 M
$26.10 K(-105.1%)
-$1.35 M(-45.1%)
Sep 2012
-
-$507.20 K(+233.7%)
-$2.46 M(+11.7%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$152.00 K(-78.8%)
-$2.20 M(-4.5%)
Mar 2012
-
-$717.50 K(-33.7%)
-$2.31 M(+14.8%)
Dec 2011
-$2.01 M(-50.1%)
-$1.08 M(+334.0%)
-$2.01 M(+22.3%)
Sep 2011
-
-$249.40 K(-2.5%)
-$1.64 M(-15.0%)
Jun 2011
-
-$255.70 K(-39.2%)
-$1.93 M(-44.6%)
Mar 2011
-
-$420.30 K(-41.3%)
-$3.49 M(-13.3%)
Dec 2010
-$4.02 M(+53.6%)
-$716.20 K(+32.9%)
-$4.02 M(-2.5%)
Sep 2010
-
-$539.00 K(-70.2%)
-$4.12 M(-9.5%)
Jun 2010
-
-$1.81 M(+89.3%)
-$4.56 M(+49.3%)
Mar 2010
-
-$956.90 K(+17.1%)
-$3.06 M(+16.6%)
Dec 2009
-$2.62 M(+122.7%)
-$817.40 K(-16.1%)
-$2.62 M(+29.4%)
Sep 2009
-
-$974.30 K(+217.9%)
-$2.02 M(+59.5%)
Jun 2009
-
-$306.50 K(-41.2%)
-$1.27 M(-6.8%)
Mar 2009
-
-$521.60 K(+135.4%)
-$1.36 M(+92.9%)
Dec 2008
-$1.18 M(-44.6%)
-$221.60 K(+1.0%)
-$706.20 K(-16.6%)
Sep 2008
-
-$219.40 K(-45.1%)
-$846.30 K(-34.7%)
Jun 2008
-
-$399.50 K(-397.5%)
-$1.30 M(-4.3%)
Mar 2008
-
$134.30 K(-137.1%)
-$1.35 M(-36.2%)
Dec 2007
-$2.12 M(-33.8%)
-$361.70 K(-45.9%)
-$2.12 M(-3.1%)
Sep 2007
-
-$668.40 K(+46.0%)
-$2.19 M(+1.2%)
Jun 2007
-
-$457.90 K(-27.8%)
-$2.16 M(-25.3%)
Mar 2007
-
-$633.80 K(+47.9%)
-$2.89 M(-1.7%)
Dec 2006
-$3.21 M(+17.4%)
-$428.60 K(-33.2%)
-$2.94 M(-3.8%)
Sep 2006
-
-$641.50 K(-46.1%)
-$3.06 M(-24.1%)
Jun 2006
-
-$1.19 M(+73.6%)
-$4.03 M(+26.5%)
Mar 2006
-
-$685.20 K(+25.8%)
-$3.19 M(+13.2%)
Dec 2005
-$2.73 M(-28.9%)
-$544.60 K(-66.2%)
-$2.82 M(+0.2%)
Sep 2005
-
-$1.61 M(+365.1%)
-$2.81 M(+30.8%)
Jun 2005
-
-$346.50 K(+10.6%)
-$2.15 M(-15.4%)
Mar 2005
-
-$313.30 K(-42.0%)
-$2.54 M(-33.8%)
Dec 2004
-$3.84 M(+610.5%)
-$540.00 K(-43.2%)
-$3.84 M(+0.1%)
Sep 2004
-
-$950.10 K(+28.5%)
-$3.84 M(+32.8%)
Jun 2004
-
-$739.10 K(-54.2%)
-$2.89 M(+34.3%)
Mar 2004
-
-$1.61 M(+199.9%)
-$2.15 M(+297.9%)
Dec 2003
-$540.80 K(>+9900.0%)
-$537.80 K(>+9900.0%)
-$540.90 K(>+9900.0%)
Sep 2003
-
-$600.00(0.0%)
-$3700.00(0.0%)
Jun 2003
-
-$600.00(-68.4%)
-$3700.00(0.0%)
Mar 2003
-
-$1900.00(+216.7%)
-$3700.00(+8.8%)
Dec 2002
-$3400.00(+61.9%)
-$600.00(0.0%)
-$3400.00(0.0%)
Sep 2002
-
-$600.00(0.0%)
-$3400.00(0.0%)
Jun 2002
-
-$600.00(-62.5%)
-$3400.00(0.0%)
Mar 2002
-
-$1600.00(+166.7%)
-$3400.00(+70.0%)
Dec 2001
-$2100.00(-41.7%)
-$600.00(0.0%)
-$2000.00(-54.5%)
Sep 2001
-
-$600.00(0.0%)
-$4400.00(0.0%)
Jun 2001
-
-$600.00(+200.0%)
-$4400.00(+15.8%)
Mar 2001
-
-$200.00(-93.3%)
-$3800.00(+5.6%)
Dec 2000
-$3600.00
-$3000.00(+400.0%)
-$3600.00(+500.0%)
Sep 2000
-
-$600.00(-96.1%)
-$600.00(-96.1%)
Sep 1999
-
-$15.20 K
-$15.20 K

FAQ

  • What is ZIVO Bioscience annual EBITDA?
  • What is the all time high annual EBITDA for ZIVO Bioscience?
  • What is ZIVO Bioscience annual EBITDA year-on-year change?
  • What is ZIVO Bioscience quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ZIVO Bioscience?
  • What is ZIVO Bioscience quarterly EBITDA year-on-year change?
  • What is ZIVO Bioscience TTM EBITDA?
  • What is the all time high TTM EBITDA for ZIVO Bioscience?
  • What is ZIVO Bioscience TTM EBITDA year-on-year change?

What is ZIVO Bioscience annual EBITDA?

The current annual EBITDA of ZIVO is -$7.26 M

What is the all time high annual EBITDA for ZIVO Bioscience?

ZIVO Bioscience all-time high annual EBITDA is $1.22 M

What is ZIVO Bioscience annual EBITDA year-on-year change?

Over the past year, ZIVO annual EBITDA has changed by +$1.47 M (+16.82%)

What is ZIVO Bioscience quarterly EBITDA?

The current quarterly EBITDA of ZIVO is -$2.26 M

What is the all time high quarterly EBITDA for ZIVO Bioscience?

ZIVO Bioscience all-time high quarterly EBITDA is $4.11 M

What is ZIVO Bioscience quarterly EBITDA year-on-year change?

Over the past year, ZIVO quarterly EBITDA has changed by -$363.40 K (-19.16%)

What is ZIVO Bioscience TTM EBITDA?

The current TTM EBITDA of ZIVO is -$13.66 M

What is the all time high TTM EBITDA for ZIVO Bioscience?

ZIVO Bioscience all-time high TTM EBITDA is $1.22 M

What is ZIVO Bioscience TTM EBITDA year-on-year change?

Over the past year, ZIVO TTM EBITDA has changed by -$6.40 M (-88.10%)